The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Amgen (Inst); Novartis (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche Pharma AG
Pazopanib and 5-FU/oxaliplatin as first-line treatment in advanced gastric cancer: PaFLO, a randomized phase II study from the AIO (Arbeitsgemeinschaft Internistische Onkologie).
 
Peter C. Thuss-Patience
Honoraria - Amgen; Roche Pharma AG
Consulting or Advisory Role - Lilly; Roche Pharma AG
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - Teva
 
Salah-Eddin Al-Batran
No Relationships to Disclose
 
Jens T Siveke
No Relationships to Disclose
 
Nils Homann
No Relationships to Disclose
 
Peter Malfertheiner
No Relationships to Disclose
 
Dietrich Glaeser
No Relationships to Disclose
 
Alexander Stein
No Relationships to Disclose
 
Ingo Tamm
Honoraria - Bristol-Myers Squibb; Lilly; Novartis; Roche Pharma AG; Teva
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Roche Pharma AG; Teva
 
Severin Daum
No Relationships to Disclose
 
Jochem Potenberg
No Relationships to Disclose
 
Axel Florschütz
Honoraria - Celgene; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen
 
Arndt Vogel
Honoraria - Amgen; Celgene; Lilly; Roche/Genentech
Consulting or Advisory Role - Amgen; Bayer; Celgene; Lilly; Roche/Genentech
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Lilly; Roche Pharma AG
 
Karsten Ridwelski
No Relationships to Disclose
 
Matthias Ritgen
No Relationships to Disclose
 
Michael Geissler
No Relationships to Disclose
 
Harald Schmalenberg
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Research Funding - Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis
 
Peter Schlattmann
No Relationships to Disclose
 
Mario Lorenz
No Relationships to Disclose
 
Kirstin Breithaupt
No Relationships to Disclose
 
Uwe Pichlmeier
No Relationships to Disclose